Rockwell Medical (RMTI) Profit After Tax (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Profit After Tax came in at -$1.6 million in Q1 2026, down 5.94% YoY from -$1.7 million in Q1 2025, and down 189.71% on a QoQ basis from -$554000.0 in Q4 2025.
Rockwell Medical (RMTI) Profit After Tax (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Profit After Tax data on file, last reported at -$1.6 million in Q1 2026.
- Quarterly Profit After Tax fell 5.94% year-over-year to -$1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (down 1946.97% YoY) and the FY2025 annual result came in at -$5.3 million, down 1007.08% from the prior year.
- Profit After Tax retreated to -$1.6 million in Q1 2026, from -$554000.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $1.7 million in Q3 2024 to a low of -$7.2 million in Q1 2022.
- A 5-year average of -$2.0 million and a median of -$1.7 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2024 — Profit After Tax surged 188.89% — and 2025, when it tumbled 534.99%.
- Tracing RMTI's Profit After Tax over 5 years: stood at -$2.4 million in 2022, then soared by 35.99% to -$1.5 million in 2023, then jumped by 50.0% to -$756000.0 in 2024, then rose by 26.72% to -$554000.0 in 2025, then sank by 189.71% to -$1.6 million in 2026.
- The last three Profit After Tax figures came in at -$1.6 million (Q1 2026), -$554000.0 (Q4 2025), and -$1.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Rockwell Medical | 29.81 Mn | 5.01 Mn | 3.24 Mn | -1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.17 Mn |
| Mar 31, 2026 | -1.61 Mn |
| Dec 31, 2025 | -554,000.00 |
| Sep 30, 2025 | -1.75 Mn |
| Jun 30, 2025 | -1.49 Mn |
| Mar 31, 2025 | -1.52 Mn |
| Dec 31, 2024 | -756,000.00 |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 343,000.00 |
| Mar 31, 2024 | -1.73 Mn |
| Dec 31, 2023 | -1.51 Mn |
| Sep 30, 2023 | -1.87 Mn |
| Jun 30, 2023 | -3.31 Mn |
| Mar 31, 2023 | -1.75 Mn |
| Dec 31, 2022 | -2.36 Mn |
| Sep 30, 2022 | -4.19 Mn |
| Jun 30, 2022 | -4.97 Mn |
| Mar 31, 2022 | -7.16 Mn |
| Dec 31, 2021 | -8.94 Mn |
| Sep 30, 2021 | -7.58 Mn |